about
IL-15Rα deficiency in skeletal muscle alters respiratory function and the proteome of mitochondrial subpopulations independent of changes to the mitochondrial genomePeripheral blood AKAP7 expression as an early marker for lymphocyte-mediated post-stroke blood brain barrier disruptionLoss of Adipocyte VEGF Impairs Endurance Exercise Capacity in MiceThe Role of Arginase 1 in Post-Stroke Immunosuppression and Ischemic Stroke Severity.Circulating leucocytes perpetuate stroke-induced aortic dysfunction.Interleukin-15 directly stimulates pro-oxidative gene expression in skeletal muscle in-vitro via a mechanism that requires interleukin-15 receptor alpha.Stroke-associated pattern of gene expression previously identified by machine-learning is diagnostically robust in an independent patient population.Muscle-specific deletion of exons 2 and 3 of the IL15RA gene in mice: effects on contractile properties of fast and slow muscles.Monocyte-lymphocyte cross-communication via soluble CD163 directly links innate immune system activation and adaptive immune system suppression following ischemic stroke.High Interspecimen Variability in Nucleic Acid Extraction Efficiency Necessitates the Use of Spike-In Control for Accurate qPCR-based Measurement of Plasma Cell-Free DNA Levels.Leukocyte Dynamics Influence Reference Gene Stability in Whole Blood: Data-Driven qRT-PCR Normalization Is a Robust Alternative for Measurement of Transcriptional Biomarkers.Machine-learning approach identifies a pattern of gene expression in peripheral blood that can accurately detect ischaemic stroke.Use of high-sensitivity digital ELISA improves the diagnostic performance of circulating brain-specific proteins for detection of traumatic brain injury during triageHigh-Throughput Profiling of Circulating Antibody Signatures for Stroke Diagnosis Using Small Volumes of Whole BloodNeuro biomarker levels measured with high-sensitivity digital ELISA differ between serum and plasmaBioinformatic analysis of brain-specific miRNAs for identification of candidate traumatic brain injury blood biomarkers
P50
Q29248840-C16BCF83-B6DA-4A8E-885C-199BD864E2ABQ33683067-E3291BB5-0295-4B61-9787-C141CA9EB166Q36274615-46AC7499-984A-483B-A60B-4118A35A4251Q36627451-9CB473AC-6A4F-47C4-8B99-B0CD2B26031DQ38665276-452027A0-24FE-48EF-A288-1D4D3C41FBA3Q38909673-27C76241-D1A5-4331-B774-EC0E5B5D7727Q41184350-42903CFF-B40E-45C2-B173-558B5014A203Q41693317-AC8D482F-2AB0-4990-95CD-B5C8A06528FFQ42374943-6A8DCE82-B246-4605-ADDF-76ACD31BA28BQ45070192-7E72A929-A0A2-48A9-A8DF-E4A4595D9F0AQ45070996-54FFEFCC-1E32-4EAA-9B2D-6EC3B923BE77Q46950395-AF7CFF1B-5718-4C6E-BFDF-C78EC2267883Q89672001-CCD252D2-B1A0-41AD-972E-821A6B9F750BQ91733382-98E4C7A4-1B6D-42A1-BB13-BD033A957C6CQ91914570-76651DDF-ECCC-4AAE-B61A-014B432A9033Q96123601-A161F93C-A124-404B-AFB6-ECAD727E2E69
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Grant C O'Connell
@ast
Grant C O'Connell
@en
Grant C O'Connell
@es
Grant C O'Connell
@nl
Grant C O'Connell
@sl
type
label
Grant C O'Connell
@ast
Grant C O'Connell
@en
Grant C O'Connell
@es
Grant C O'Connell
@nl
Grant C O'Connell
@sl
prefLabel
Grant C O'Connell
@ast
Grant C O'Connell
@en
Grant C O'Connell
@es
Grant C O'Connell
@nl
Grant C O'Connell
@sl
P106
P31
P496
0000-0002-2642-6670